Guerrini, G.; Gioria, S.; Sauer, A.V.; Lucchesi, S.; Montagnani, F.; Pastore, G.; Ciabattini, A.; Medaglini, D.; Calzolai, L.
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration. Int. J. Mol. Sci. 2022, 23, 8838.
https://doi.org/10.3390/ijms23168838
AMA Style
Guerrini G, Gioria S, Sauer AV, Lucchesi S, Montagnani F, Pastore G, Ciabattini A, Medaglini D, Calzolai L.
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration. International Journal of Molecular Sciences. 2022; 23(16):8838.
https://doi.org/10.3390/ijms23168838
Chicago/Turabian Style
Guerrini, Giuditta, Sabrina Gioria, Aisha V. Sauer, Simone Lucchesi, Francesca Montagnani, Gabiria Pastore, Annalisa Ciabattini, Donata Medaglini, and Luigi Calzolai.
2022. "Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration" International Journal of Molecular Sciences 23, no. 16: 8838.
https://doi.org/10.3390/ijms23168838
APA Style
Guerrini, G., Gioria, S., Sauer, A. V., Lucchesi, S., Montagnani, F., Pastore, G., Ciabattini, A., Medaglini, D., & Calzolai, L.
(2022). Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration. International Journal of Molecular Sciences, 23(16), 8838.
https://doi.org/10.3390/ijms23168838